CATORI: A Study to Characterize Access to Specialty Care Received by American Indians/Alaska Natives
Study Details
Study Description
Brief Summary
This is an observational study to define current care pathways for American Indian or Alaska Native patients requiring specialty care and potential feasibility of conducting clinical research within the existing framework. The study is designed with the flexibility to enroll patients with any indication requiring referral to a specialist (neurologist, ophthalmologist, or oncologist). Eligible patients will have recently (<3 months) been referred to a specialty care provider and not yet seen.
The study will collect data to determine whether a patient was seen by a specialist, diagnosed with a specialized disease, patient characteristics potentially associated with being seen or not seen by a specialist, and the reasons/barriers why a patient was not seen by a specialist through a number of patient surveys.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Specialist Referral: Neurology
|
Other: No Intervention
Participants who self-identify as American Indian or Alaska Native with any indication requiring referral to a specialist after a primary care provider standard of care visit will be observed to collect data, using several surveys at 6 and 12 months. No additional specialty care visits will be added for the purpose of this study given the intent to observe medical care received following primary care provider referral. Referral to a specialist will be based on local clinical practice.
|
| Specialist Referral: Ophthalmology
|
Other: No Intervention
Participants who self-identify as American Indian or Alaska Native with any indication requiring referral to a specialist after a primary care provider standard of care visit will be observed to collect data, using several surveys at 6 and 12 months. No additional specialty care visits will be added for the purpose of this study given the intent to observe medical care received following primary care provider referral. Referral to a specialist will be based on local clinical practice.
|
| Specialist Referral: Oncology
|
Other: No Intervention
Participants who self-identify as American Indian or Alaska Native with any indication requiring referral to a specialist after a primary care provider standard of care visit will be observed to collect data, using several surveys at 6 and 12 months. No additional specialty care visits will be added for the purpose of this study given the intent to observe medical care received following primary care provider referral. Referral to a specialist will be based on local clinical practice.
|
Outcome Measures
Primary Outcome Measures
- Percentage of Participants Seen by a Specialist for Advanced Care After Primary Care Provider Referral to a Specialist at 6 Months [6 Months]
- Percentage of Participants Seen by a Specialist for Advanced Care After Primary Care Provider Referral to a Specialist at 12 Months [12 Months]
Secondary Outcome Measures
- Percentage of Participants Seen by a Specialist and Treated for Their Disease at 6 Months [6 Months]
- Percentage of Participants Seen by a Specialist and Treated for Their Disease at 12 Months [12 Months]
- Percentage of Responses by Participant-Reported Barriers to Specialty Referral Completion at 6 Months [6 Months]
- Percentage of Responses by Participant-Reported Barriers to Specialty Referral Completion at 12 Months [12 Months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Ability to read English at 8th grade proficiency or have a household member willing to assist in translation to complete patient surveys
-
Self-identification as American Indian or Alaska Native
-
Referred to a neurologist, ophthalmologist, or oncologist for the first time
-
Personal landline or cell phone and/or access to internet
-
Willingness to complete all surveys in the study and participate for 12 months
Exclusion Criteria:
-
Currently under the care of a specialist (>3 months) to whom they are being referred to by the primary care provider (i.e., to be eligible, the specialty care physician should be new to the participant)
-
Currently or planned to receive care that requires in participant visits for the indication requiring referral from the primary care provider (e.g., radiotherapy, chemotherapy for cancer diagnosis) within 3 months of consent date
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Curebase | Walnut | California | United States | 91789 |
| 2 | Avera Research Institute | Sioux Falls | South Dakota | United States | 57105 |
Sponsors and Collaborators
- Genentech, Inc.
Investigators
- Study Director: Clinical Trials, Genentech, Inc.
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ML44072